Equities

Human Metabolome Technologies Inc

6090:TYO

Human Metabolome Technologies Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)602.00
  • Today's Change-2.00 / -0.33%
  • Shares traded4.90k
  • 1 Year change-10.42%
  • Beta1.3706
Data delayed at least 20 minutes, as of Nov 22 2024 06:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
OPERATIONS
Net income262237262
Depreciation/depletion868065
Non-Cash items(11)4.70(28)
Cash taxes paid, supplemental153715
Cash interest paid, supplemental2.102.272.21
Changes in working capital(100)(37)25
Total cash from operations237285324
INVESTING
Capital expenditures(34)(117)(146)
Other investing and cash flow items, total1.660.10(6.2)
Total cash from investing(32)(117)(152)
FINANCING
Financing cash flow items0.000.000.00
Total cash dividends paid(59)----
Issuance (retirement) of stock, net--(0.02)--
Issuance (retirement) of debt, net(14)(14)80
Total cash from financing(73)(14)80
NET CHANGE IN CASH
Foreign exchange effects0.52(2.41)7.48
Net change in cash132152260
Net cash-begin balance/reserved for future use1,6571,5051,245
Net cash-end balance/reserved for future use1,7891,6571,505
SUPPLEMENTAL INCOME
Depreciation, supplemental868065
Cash interest paid, supplemental2.102.272.21
Cash taxes paid, supplemental153715
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.